Neuroscience Antibodies & Assays Market Growth Forecast: Exploring Trends and Opportunities for the Next Decade
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the neuroscience antibodies & assays market size evolved in recent years?
In the past few years, the market size for neuroscience antibodies & assays has seen significant growth. It is projected to expand from $4.52 billion in 2024 to $5.07 billion in 2025, with a compound annual growth rate (CAGR) of 12.2%. Reasons for this increase during the historic period include research funding, advancements in drug discovery and development, the presence of neurodegenerative diseases, government-led initiatives, and the development of personalized medicine.
What are the predictions for the neuroscience antibodies & assays market size in the coming years?
The market size for neuroscience antibodies and assays is anticipated to expand rapidly in the upcoming years, reaching a value of $8.74 billion in 2029, with a compound annual growth rate (CAGR) of 14.6%. Various factors contribute to this projected growth during the forecast period, including partnerships, the utilization of telemedicine in neurology, education and training, biomarker-driven therapies, and a focus on neuroimmunology. Notable trends for the period include the use of microrna and non-coding rna assays, digital pathology, advanced imaging-compatible assays, single-cell analysis, and 3D organoid models.
Get your neuroscience antibodies & assays market report here!
What key factors are fueling the growth of the neuroscience antibodies & assays market?
The growth of the neuroscience antibodies & assays market is predicted to be driven by the upsurge in cases of neurological illnesses worldwide. Neurological illnesses, which consist of disorders impacting the nervous system such as epilepsy, Alzheimer’s disease, dementia and others, are on the rise. This calls for increased research and development activities to devise treatments for these illnesses. Techniques involving antibodies and assays are fundamental to researching the development, systems, structure, function, disorders, and degeneration of the nervous system, implying the market growth for neuroscience antibodies & assays is bolstered by rising neurological illness incidents. For instance, in May 2024, about 2.9 million U.S. adults aged 18 and over were reported to have active epilepsy during 2021 and 2022, according to Centers for Disease Control and Prevention, a US-based federal agency. The Alzheimer’s Association, a US-based non-profit organization, reported that 6.5 million people in the US suffered from Alzheimer’s disease as per the 2022 data. Therefore, the escalating prevalence of neurological illnesses worldwide is fueling the advancement of the neuroscience antibodies and assays market.
How is the global neuroscience antibodies & assays market divided into key segments?
The neuroscience antibodies & assays market covered in this report is segmented –
1) By Product: Consumables, Instruments
2) By Technology: Molecular Diagnostics, Clinical Chemistry, Immunoassays Or Immunochemistry, Others Technologies
3) By Application: In Vitro Diagnostics, Research, Drug Discovery
4) By End User: Hospitals And Diagnostics Centers, Academic And Research Institutes, Pharmaceutical And Biotechnology Companies
Subsegments:
1) By Consumables: Antibodies, Assay Kits, Assay Kits
2) By Instruments: Spectrophotometers, Microplate Readers, Flow Cytometers, Western Blotting Systems, Imaging Systems, Automated Workstations
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7548&type=smp
Who are the key firms paving the way for growth in the neuroscience antibodies & assays market?
Major companies operating in the neuroscience antibodies & assays market include Abcam plc, BioLegend Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Merck KGaA, Rockland Immunochemicals Inc., GenScript Biotech Corporation, Santa Cruz Biotechnology Inc., Wak-Chemie Medical GmbH, Epitope Diagnostics Inc., Agilent Technologies, Bio-Techne Corporation, Creative Diagnostics, Enzo Life Sciences Inc., Jackson ImmunoResearch Laboratories Inc., Novus Biologicals LLC, OriGene Technologies Inc., Proteintech Group Inc., R&D Systems Inc., RayBiotech Inc., StressMarq Biosciences Inc., Synaptic Systems GmbH, Tocris Bioscience, Alomone Labs Ltd., AnaSpec Inc., Antibodies.com, Antibody Solutions, Arbor Assays, Uscn Life Science Inc., Zymo Research Corp., AAT Bioquest Inc., Abbexa Ltd., ACROBiosystems Inc., Active Motif Inc., AdipoGen Life Sciences, Advanced Targeting Systems Inc., AgriSera AB
Which trends are expected to transform the neuroscience antibodies & assays market?
The emergence of technological advancements is a significant trend gaining traction in the neuroscience antibodies and assays industry with leading companies launching novel technologies like the NeuroNexus Summa Framework technology, to maintain their market stronghold. An example of such an advancement was in February 2022 when NeuroNexus Technologies, a pioneering provider of neural interface products and technologies based in the U.S, unveiled the NeuroNexus Summa Framework. The tool was engineered to serve both seasoned electrophysiologists and life science researchers aiming to seamlessly integrate electrical signal readings from biological cells and tissues into their research processes.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7548
What regions are contributing significantly to the growth of the neuroscience antibodies & assays market?
North America was the largest region in the neuroscience antibodies & assays market in 2024. The regions covered in the neuroscience antibodies & assays market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Browse Through More Similar Reports By The Business Research Company:
Neurostimulation Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/neurostimulation-devices-global-market-report
Neurology Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/neurology-devices-global-market-report
Neurosurgery Devices And Equipment Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
